09/27/2022: Lab Advisory: FDA Updates COVID-19 Test Policy and FAQs

CDC's Laboratory Outreach Communication System (LOCS)

Audience: Laboratory and Testing Professionals

Level: Laboratory Advisory

On September 27, 2022, the U.S. Food and Drug Administration (FDA) updated its COVID-19 test policy to address public health testing needs during this phase of the COVID-19 public health emergency. The FDA is revising its COVID-19 test policy to encourage most COVID-19 test developers to pursue a traditional premarket review pathway for their tests rather than emergency use authorization.

Please review the revised Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency and updated FAQs on Testing for SARS-CoV-2 and share this message with your networks.

Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS).

Resources

Questions?

Thank you,

The Laboratory Outreach Communication System

Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)

Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)

Centers for Disease Control and Prevention (CDC)

LOCS@cdc.gov

www.cdc.gov/locs

Page last reviewed: September 27, 2022